Effect of prior systemic therapy on clinical outcomes with cabozantinib vs everolimus in advanced renal cell carcinoma: Results from the phase 3 METEOR study Meeting Abstract


Authors: Grande, E.; Choueiri, T. K.; Motzer, R. J.; Escudier, B.; Pal, S.; Kollmannsberger, C.; Pikiel, J.; Gurney, H.; Rha, S. Y.; Park, S. H.; Geertsen, P. F.; Goupil, M. G.; Suarez, C.; Arroyo, A.; Dean, M.; George, D.; Powles, T.
Abstract Title: Effect of prior systemic therapy on clinical outcomes with cabozantinib vs everolimus in advanced renal cell carcinoma: Results from the phase 3 METEOR study
Meeting Title: ECCO2017: European Cancer Congress
Journal Title: European Journal of Cancer
Volume: 72
Issue: Suppl. 1
Meeting Dates: 2017 Jan 27-30
Meeting Location: Amsterdam, Netherlands
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2017-02-01
Start Page: S197
End Page: S198
Language: English
ACCESSION: WOS:000417650200618
PROVIDER: wos
DOI: 10.1016/S0959-8049(17)30707-4
Notes: Meeting Abstract: 2199 -- ECCO European Cancer Congress -- JAN 27-30, 2017 -- Amsterdam, NETHERLANDS -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer